Cancer Cytopathology · 2018 · 56 citations · 17 references
MedicineOncologyPathologyCytopathologyNeoplasiaTumor PathologyEndocrine Tumor DiagnosisEndocrine TumorsNeuroendocrine TumorsTumor CharacterizationTumor CytopathologyTumor MarkersCarcinoid Tumor DiagnosisLarge Cell Neuroendocrine CarcinomaLung Cancer CytologyNeuroendocrine Tumor HistologyNon-small Cell Lung Carcinoma CytologyPulmonary Neuroendocrine TumorsSmall Cell Lung Carcinoma CytologySurgical Specimen Evaluation
BACKGROUND: Recent studies suggest that insulinoma-associated protein 1 (INSM1) is a sensitive and specific marker of neuroendocrine neoplasms. The aims of this study were to determine whether INSM1 can be reliably used in cytology (Cellient) cell blocks, to ascertain whether staining correlates with paired surgical pathology specimens, and to compare its sensitivity and specificity with those of synaptophysin (SYN), chromogranin (CHR), and CD56 for neuroendocrine lung tumors. METHODS: Seventy-four primary lung neoplasms diagnosed on cytology were stained with INSM1, SYN, CHR, and CD56: 41 small cell lung carcinomas (SCLCs), 1 large cell neuroendocrine carcinoma (LCNEC), 10 carcinoid tumors, 11 adenocarcinomas, 9 squamous cell carcinomas, 1 mesothelioma and 1 poorly differentiated non-small cell lung carcinoma, not otherwise specified. In 20 cases, a paired surgical pathology specimen was also stained with INSM1. RESULTS: INSM1 was positive in 48 of 52 primary lung neuroendocrine neoplasms (92%), including 38 of 41 SCLCs (93%), the only LCNEC (100%), and 9 of 10 carcinoid tumors (90%), and it was negative in all 22 non-neuroendocrine primary lung tumors. For SCLC, the sensitivity of INSM1 (93%) was lower than the sensitivity of CD56 (100%), equal to the sensitivity of SYN (93%), and higher than the sensitivity of CHR (35%). For carcinoid tumors, the sensitivity of INSM1 (90%) was lower than the sensitivity of all other markers (100% each). The specificity of INSM1 for neuroendocrine neoplasms as a group was 100%. INSM1 staining was concordant with surgical pathology specimens in all 20 paired cases. CONCLUSIONS: INSM1 can be used in cytopathology cell blocks, and it is sensitive and highly specific for neuroendocrine lung tumors. INSM1 staining in cytology cell blocks correlates well with surgical pathology specimens. Cancer Cytopathol 2018;126:243-52. © 2018 American Cancer Society.
17
Small Cell Lung Carcinoma (SCLC)
Siobhan Nicholson, Mary Beth Beasley, E. Brambilla et al. · The American Journal of Surgical Pathology · 2002 · 396 citations
Lisa M. Rooper, Rajni Sharma, Qing Kay Li et al. · The American Journal of Surgical Pathology · 2017 · 175 citations
Medicine, Endocrinology, Oncology +17